Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03655119 · ClinicalTrials.gov registry record · NA

PES Family Support and Follow-Up Program

A NA study, sponsored by University of Michigan.

Terminated
Registry status
NA
Development phase
229
Enrollment target

NCT03655119: Clinical Trial NA study, sponsored by University of Michigan.

NCT03655119 is a NA study that was terminated before completion, run by University of Michigan. The registered enrollment target is 229 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03655119, a NA study, was terminated before completion, sponsored by University of Michigan.

TERMINATED
Registry status
NA
Development phase
229 participants
Enrollment target

Study Summary

The Psychiatric Emergency Services (PES) Family Support and Follow-Up Program is a service delivery intervention that utilizes a multi-component approach to enhance usual care provided to youth and families at the University of Michigan Psychiatric Emergency Services in order to promote youth safety and provide support to families following their visit. During the first phase of intervention, families will receive enhanced usual care by clinical staff along with a family toolkit that includes a youth safety plan and written recommendations for safety monitoring and supporting youth during a crisis. During the second phase of intervention, families will receive the interventions provided during the first phase in addition to caring contacts post discharge, which may occur by phone, text, or email. Caring contacts are meant to provide support, additional education, and problem solving assistance.

Primary Outcome

Change in the number of families' engaging in safety recommendations including means restriction in the home, safety planning, and risk assessment as measured by yes/no response.

Interventions

  • BEHAVIORAL Enhanced Care
  • BEHAVIORAL Parent toolkit
  • BEHAVIORAL Caring Follow-Up Messages

Trial Details

FieldValue
Enrollment Target 229 participants
Start Date 2018-09-10
Est. Completion 2020-03-11
Phase NA
University of Michigan

1,327 total trials

Why NCT03655119 stopped before completion

NCT03655119 is an interventional study that assigns participants to a tested intervention. The registered 229 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).

The record links to 0 conditions, and to 3 interventions - of which Enhanced Care is the first listed.

NCT03655119 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03655119 about?

NCT03655119 is a clinical study titled "PES Family Support and Follow-Up Program". The Psychiatric Emergency Services (PES) Family Support and Follow-Up Program is a service delivery intervention that utilizes a multi-component approach to enhance usual care provided to youth and families at the University of Michigan Psychiatric Emergency Services in order to promote youth safety...

What is the current status of trial NCT03655119?

This trial is currently terminated. It is a NA study. The enrollment target is 229 participants. The study started on 2018-09-10. Estimated completion is 2020-03-11.

What interventions are being tested in trial NCT03655119?

The interventions under investigation include: Enhanced Care (BEHAVIORAL), Parent toolkit (BEHAVIORAL), Caring Follow-Up Messages (BEHAVIORAL).

Who is sponsoring clinical trial NCT03655119?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03655119's enrollment target sits among peer trials

229 468th of 2000 higher than 1,533 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02710253 · 230 participants · Phase 2

    Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy

  • NCT02777879 · 230 participants

    Lung Microbiome and Inflammation in Early COPD

  • NCT03824483 · 230 participants · Phase 2

    Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)

  • NCT03833622 · 230 participants · NA

    Shared Decision Making to Improve Goals of Care in the ED

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03655119, the US trial registry maintained by the National Library of Medicine. NCT03655119 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.